MXCT vs V
MaxCyte Inc (MXCT) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
MXCT currently screens at market cap $124.3M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the MXCT and V stock pages for the full models.
Not investment advice.